Get the Stockscreener App
64.49
0.26%
0.17
Hologic Inc stock is traded at $64.49, with a volume of 2.17M.
It is up +0.26% in the last 24 hours and down -8.36% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$64.32
Open:
$64.2
24h Volume:
2.17M
Relative Volume:
0.96
Market Cap:
$14.64B
Revenue:
$4.03B
Net Income/Loss:
$789.50M
P/E Ratio:
19.37
EPS:
3.33
Net Cash Flow:
$1.15B
1W Performance:
+1.98%
1M Performance:
-8.36%
6M Performance:
-19.41%
1Y Performance:
-14.94%
1-Day Range:
$63.76
$64.70
1-Week Range:
$62.70
$65.18
52-Week Range:
$62.70
$84.67
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
64.49 | 14.64B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Do Options Traders Know Something About Hologic (HOLX) Stock We Don't? - Yahoo Finance
BioZorb Lawsuit - Lawsuit Information Center Blog
Digital X-ray Devices Market Witnessing High Demand | Key Trends - openPR
Fluoroscopy Devices Market Set to Expand | Innovations, - openPR
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2025: Key Trends, Major Players, Opportunities, Strategies, M&As, 2018-2023, 2028F, 2033F - GlobeNewswire Inc.
Global Stereotactic Breast Biopsy Market Overview, Future - openPR
Hologic Gains CE Mark for Affirm Contrast Biopsy Software - MPO-mag
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software - Silicon Canals
Can This New Biopsy Technology Transform Breast Cancer Detection in Europe? - StockTitan
Breast Cancer Diagnostic Market: Imaging Advancements, Growth - openPR
Molecular Diagnostics Market: Is Booming Worldwide 2024-2032 | Hologic, Abbott, MDxHealth - openPR
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay - BioSpace
FDA OKs Hologic’s Aptima SARS-CoV-2 Assay - MPO-mag
Hologic's SWOT analysis: diagnostics firm faces growth challenges By Investing.com - Investing.com South Africa
Hologic's SWOT analysis: diagnostics firm faces growth challenges - Investing.com India
These 4 Big Cap Health Care Stocks Just Hit New 52-Week Lows - Forbes
Morcellator Market SWOT Analysis by Key Players- Karl Storz, Hologic, Medtronic - openPR
Cervical Cytology Brushes Market Booming Growth: Future - openPR
Why Hologic (HOLX) Outpaced the Stock Market Today - MSN
Entropy Technologies LP Trims Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 15,820 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Gynecological Devices Market Projected To Witness Substantial Growth, 2025-2032 | Ethicon, Inc., Hologic, Inc, - EIN News
Leerink Partnrs Has Positive Outlook of Hologic Q4 Earnings - MarketBeat
William Blair Has Pessimistic View of Hologic Q2 Earnings - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Receives $85.77 Consensus Price Target from Analysts - MarketBeat
Hologic (NASDAQ:HOLX) Hits New 1-Year LowWhat's Next? - MarketBeat
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes - MSN
Hologic Stock: Analyst Estimates & Ratings - Nasdaq
Here's Why You Should Retain HOLX Stock in Your Portfolio Now - Nasdaq
Global Access Initiative - Hologic
Biopsy Devices Market Booming Demand, Growth Opportunities, - openPR
Stephens Investment Management Group LLC Has $53.89 Million Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - MSN
North America Diagnostic Imaging Market to Drive Growth with - openPR
Leerink Partnrs Has Pessimistic View of Hologic Q3 Earnings - MarketBeat
William Blair Estimates Hologic's Q3 Earnings (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deciphering Hologic (HOLX) International Revenue Trends - Nasdaq
Hologic (NASDAQ:HOLX) Price Target Cut to $85.00 by Analysts at Royal Bank of Canada - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by Lecap Asset Management Ltd. - MarketBeat
Evercore ISI Has Lowered Expectations for Hologic (NASDAQ:HOLX) Stock Price - MarketBeat
Hologic's (HOLX) Outperform Rating Reaffirmed at Raymond James - MarketBeat
Hologic shares fall 3% as Q2 guidance disappoints - MSN
HOLXHologic Inc Latest Stock News & Market Updates - StockTitan
Breast Health Performance Likely to Aid Hologic's Q1 Earnings - MSN
Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Canada Finance
abrdn plc Sells 13,484 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic is Now Oversold (HOLX) - Nasdaq
Hologic, Inc. (NASDAQ:HOLX) Just Reported, And Analysts Assigned A US$80.53 Price Target - Simply Wall St
Hologic outlines Q2 revenue guidance of $995M–$1.005B amid expected diagnostics growth - MSN
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hologic Inc Stock (HOLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Sale |
76.34 |
24,856 |
1,897,482 |
27,957 |
3.85%
3.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):